ALTIUM CAPITAL MANAGEMENT LP Holdings

ALTIUM CAPITAL MANAGEMENT LP is an investment fund managing more than 272.76M US dollars. The largest holdings include BELLUS Health, Chinook Therapeutics and ChemoCentryx. In Q3 2022 the fund bought assets of total value of 86.43M US dollars and sold assets of total value of 62.02M US dollars.

$272.75M

portfolio value

+9.49%

quarter

-31.57%

1 year

ALTIUM CAPITAL MANAGEMENT LP portfolio changes

Portfolio changes (number of shares)
Period	Buy	Sel
Q1 2021	175114000	86045000
Q2 2021	180292000	111823000
Q3 2021	86145000	122272000
Q4 2021	128873000	135123000
Q1 2022	75203000	130339000
Q2 2022	68402000	105726000
Q3 2022	86426000	62015000

ALTIUM CAPITAL MANAGEMENT LP 13F holdings

Stock	Position type	Portfolio share	Portfolio value	Avg. open price	Current price	P/L	Last change
Biotechnology BELLUS Health Inc. Portfolio share: 4.38% Portfolio value: 11.95M Avg. open price: $6.57 Current price: $10.02 P/L: +52.55% Bought +24.12% shares Q3 2022	share	4.38%	11.95M	$6.57	$10.02	+52.55%	Bought +24.12% shares Q3 2022
Biotechnology Chinook Therapeutics, Inc. Portfolio share: 3.78% Portfolio value: 10.32M Avg. open price: $14.97 Current price: $22.77 P/L: +52.12% Sold -14.63% shares Q3 2022	share	3.78%	10.32M	$14.97	$22.77	+52.12%	Sold -14.63% shares Q3 2022
Biotechnology ChemoCentryx, Inc. Portfolio share: 3.03% Portfolio value: 8.26M Avg. open price: N/A Current price: $51.99 P/L: N/A N/A Q2 2022	share	3.03%	8.26M	N/A	$51.99	N/A	N/A Q2 2022
Shell Companies PepperLime Health Acquisition Corporation Portfolio share: 2.69% Portfolio value: 7.34M Avg. open price: N/A Current price: $10.13 P/L: N/A N/A Q2 2022	share	2.69%	7.34M	N/A	$10.13	N/A	N/A Q2 2022
Biotechnology ADMA Biologics, Inc. Portfolio share: 2.57% Portfolio value: 7.00M Avg. open price: $1.83 Current price: $3.25 P/L: +77.32% Sold -27.91% shares Q3 2022	share	2.57%	7.00M	$1.83	$3.25	+77.32%	Sold -27.91% shares Q3 2022
Biotechnology CymaBay Therapeutics, Inc. Portfolio share: 2.25% Portfolio value: 6.12M Avg. open price: N/A Current price: $4.17 P/L: N/A N/A Q4 2021	share	2.25%	6.12M	N/A	$4.17	N/A	N/A Q4 2021
Biotechnology Insmed Incorporated Portfolio share: 2.12% Portfolio value: 5.77M Avg. open price: $31.3 Current price: $19.89 P/L: -36.45% Bought +31.79% shares Q1 2022	share	2.12%	5.77M	$31.3	$19.89	-36.45%	Bought +31.79% shares Q1 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 1.97% Portfolio value: 5.38M Avg. open price: N/A Current price: $51.95 P/L: N/A N/A Q3 2022	call	1.97%	5.38M	N/A	$51.95	N/A	N/A Q3 2022
Shell Companies Nocturne Acquisition Corporation Portfolio share: 1.89% Portfolio value: 5.16M Avg. open price: N/A Current price: $10.49 P/L: N/A N/A Q2 2021	share	1.89%	5.16M	N/A	$10.49	N/A	N/A Q2 2021
Medical Devices Glaukos Corporation Portfolio share: 1.89% Portfolio value: 5.16M Avg. open price: $53.1 Current price: $45.88 P/L: -13.60% Sold -14.91% shares Q3 2022	share	1.89%	5.16M	$53.1	$45.88	-13.60%	Sold -14.91% shares Q3 2022
Biotechnology Akero Therapeutics, Inc. Portfolio share: 1.75% Portfolio value: 4.76M Avg. open price: N/A Current price: $44.04 P/L: N/A N/A Q3 2022	share	1.75%	4.76M	N/A	$44.04	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Intra-Cellular Therapies, Inc. Portfolio share: 1.71% Portfolio value: 4.65M Avg. open price: $59.86 Current price: $54.25 P/L: -9.38% Bought +33.33% shares Q3 2022	share	1.71%	4.65M	$59.86	$54.25	-9.38%	Bought +33.33% shares Q3 2022
Medical Devices Xtant Medical Holdings, Inc. Portfolio share: 1.65% Portfolio value: 4.49M Avg. open price: N/A Current price: $0.58 P/L: N/A Sold -0.13% shares Q4 2021	share	1.65%	4.49M	N/A	$0.58	N/A	Sold -0.13% shares Q4 2021
Biotechnology Pliant Therapeutics, Inc. Portfolio share: 1.65% Portfolio value: 4.49M Avg. open price: N/A Current price: $17 P/L: N/A N/A Q3 2022	share	1.65%	4.49M	N/A	$17	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Esperion Therapeutics, Inc. Portfolio share: 1.62% Portfolio value: 4.42M Avg. open price: N/A Current price: $7.49 P/L: N/A Sold -43.26% shares Q3 2022	share	1.62%	4.42M	N/A	$7.49	N/A	Sold -43.26% shares Q3 2022
Biotechnology BioAtla, Inc. Portfolio share: 1.56% Portfolio value: 4.25M Avg. open price: N/A Current price: $10.52 P/L: N/A N/A Q3 2022	share	1.56%	4.25M	N/A	$10.52	N/A	N/A Q3 2022
Diagnostics & Research Illumina, Inc. Portfolio share: 1.54% Portfolio value: 4.19M Avg. open price: $288.41 Current price: $213.86 P/L: -25.85% Bought +120.00% shares Q3 2022	share	1.54%	4.19M	$288.41	$213.86	-25.85%	Bought +120.00% shares Q3 2022
Biotechnology Rhythm Pharmaceuticals, Inc. Portfolio share: 1.53% Portfolio value: 4.16M Avg. open price: N/A Current price: $27.14 P/L: N/A N/A Q3 2022	share	1.53%	4.16M	N/A	$27.14	N/A	N/A Q3 2022
Biotechnology Verona Pharma plc Portfolio share: 1.51% Portfolio value: 4.12M Avg. open price: N/A Current price: $13.57 P/L: N/A N/A Q3 2022	share	1.51%	4.12M	N/A	$13.57	N/A	N/A Q3 2022
Biotechnology Karyopharm Therapeutics Inc. Portfolio share: 1.50% Portfolio value: 4.09M Avg. open price: $6.01 Current price: $5.23 P/L: -12.95% Bought +7.14% shares Q3 2022	share	1.50%	4.09M	$6.01	$5.23	-12.95%	Bought +7.14% shares Q3 2022
Biotechnology Astria Therapeutics, Inc. Portfolio share: 1.47% Portfolio value: 4.02M Avg. open price: N/A Current price: $10.32 P/L: N/A N/A Q3 2022	share	1.47%	4.02M	N/A	$10.32	N/A	N/A Q3 2022
Shell Companies Eucrates Biomedical Acquisition Corp. Portfolio share: 1.47% Portfolio value: 4.00M Avg. open price: N/A Current price: $9.92 P/L: N/A N/A Q2 2021	share	1.47%	4.00M	N/A	$9.92	N/A	N/A Q2 2021
Medical Instruments & Supplies AngioDynamics, Inc. Portfolio share: 1.46% Portfolio value: 3.99M Avg. open price: $19.35 Current price: $12.06 P/L: -37.67% Bought +391.93% shares Q3 2022	share	1.46%	3.99M	$19.35	$12.06	-37.67%	Bought +391.93% shares Q3 2022
Biotechnology BioLineRx Ltd. Portfolio share: 1.41% Portfolio value: 3.83M Avg. open price: N/A Current price: $0.73 P/L: N/A N/A Q3 2022	share	1.41%	3.83M	N/A	$0.73	N/A	N/A Q3 2022
Biotechnology Karuna Therapeutics, Inc. Portfolio share: 1.40% Portfolio value: 3.82M Avg. open price: $126.51 Current price: $226.95 P/L: +79.39% Bought +30.77% shares Q3 2022	share	1.40%	3.82M	$126.51	$226.95	+79.39%	Bought +30.77% shares Q3 2022
Medical Instruments & Supplies ResMed Inc. Portfolio share: 1.36% Portfolio value: 3.71M Avg. open price: N/A Current price: $219.35 P/L: N/A N/A Q3 2022	share	1.36%	3.71M	N/A	$219.35	N/A	N/A Q3 2022
Medical Instruments & Supplies NanoString Technologies, Inc. Portfolio share: 1.31% Portfolio value: 3.57M Avg. open price: N/A Current price: $7.06 P/L: N/A N/A Q3 2022	share	1.31%	3.57M	N/A	$7.06	N/A	N/A Q3 2022
Medical Instruments & Supplies QuidelOrtho Corporation Portfolio share: 1.31% Portfolio value: 3.57M Avg. open price: $133.1 Current price: $93.6 P/L: -29.68% N/A Q2 2022	share	1.31%	3.57M	$133.1	$93.6	-29.68%	N/A Q2 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 1.30% Portfolio value: 3.55M Avg. open price: N/A Current price: $51.95 P/L: N/A Sold -37.14% shares Q3 2022	share	1.30%	3.55M	N/A	$51.95	N/A	Sold -37.14% shares Q3 2022
Diagnostics & Research Myriad Genetics, Inc. Portfolio share: 1.30% Portfolio value: 3.54M Avg. open price: $26.84 Current price: $20.01 P/L: -25.45% Sold -15.84% shares Q3 2022	share	1.30%	3.54M	$26.84	$20.01	-25.45%	Sold -15.84% shares Q3 2022
Medical Devices Inogen, Inc. Portfolio share: 1.30% Portfolio value: 3.54M Avg. open price: N/A Current price: $21.4 P/L: N/A Sold -6.41% shares Q3 2022	share	1.30%	3.54M	N/A	$21.4	N/A	Sold -6.41% shares Q3 2022
Medical Instruments & Supplies Akoya Biosciences, Inc. Portfolio share: 1.28% Portfolio value: 3.47M Avg. open price: N/A Current price: $12.55 P/L: N/A N/A Q2 2022	share	1.28%	3.47M	N/A	$12.55	N/A	N/A Q2 2022
Medical Devices PROCEPT BioRobotics Corporation Portfolio share: 1.23% Portfolio value: 3.35M Avg. open price: $34.99 Current price: $45.58 P/L: +30.27% Sold -17.35% shares Q3 2022	share	1.23%	3.35M	$34.99	$45.58	+30.27%	Sold -17.35% shares Q3 2022
Biotechnology Eiger BioPharmaceuticals, Inc. Portfolio share: 1.21% Portfolio value: 3.31M Avg. open price: $5.59 Current price: $4.14 P/L: -26.00% Bought +68.58% shares Q1 2022	share	1.21%	3.31M	$5.59	$4.14	-26.00%	Bought +68.58% shares Q1 2022
Biotechnology Keros Therapeutics, Inc. Portfolio share: 1.21% Portfolio value: 3.31M Avg. open price: $56.3 Current price: $50 P/L: -11.19% Sold -30.16% shares Q2 2022	share	1.21%	3.31M	$56.3	$50	-11.19%	Sold -30.16% shares Q2 2022
Diagnostics & Research Natera, Inc. Portfolio share: 1.21% Portfolio value: 3.28M Avg. open price: $113.53 Current price: $40.39 P/L: -64.42% N/A Q3 2022	share	1.21%	3.28M	$113.53	$40.39	-64.42%	N/A Q3 2022
Medical Devices Alphatec Holdings, Inc. Portfolio share: 1.10% Portfolio value: 2.98M Avg. open price: N/A Current price: $9.75 P/L: N/A N/A Q3 2022	share	1.10%	2.98M	N/A	$9.75	N/A	N/A Q3 2022
Medical Devices Nevro Corp. Portfolio share: 1.09% Portfolio value: 2.98M Avg. open price: $108.8 Current price: $43.47 P/L: -60.05% Sold -28.09% shares Q3 2022	share	1.09%	2.98M	$108.8	$43.47	-60.05%	Sold -28.09% shares Q3 2022
Drug Manufacturers—Specialty & Generic Lantheus Holdings, Inc. Portfolio share: 1.08% Portfolio value: 2.95M Avg. open price: $38.04 Current price: $56.01 P/L: +47.23% Sold -52.27% shares Q3 2022	share	1.08%	2.95M	$38.04	$56.01	+47.23%	Sold -52.27% shares Q3 2022
Medical Devices SI-BONE, Inc. Portfolio share: 1.07% Portfolio value: 2.91M Avg. open price: N/A Current price: $12.08 P/L: N/A N/A Q3 2022	share	1.07%	2.91M	N/A	$12.08	N/A	N/A Q3 2022
Biotechnology Verastem, Inc. Portfolio share: 0.93% Portfolio value: 2.55M Avg. open price: $2.88 Current price: $0.42 P/L: -85.42% Bought +1.66% shares Q2 2022	share	0.93%	2.55M	$2.88	$0.42	-85.42%	Bought +1.66% shares Q2 2022
Shell Companies Turmeric Acquisition Corp. Portfolio share: 0.93% Portfolio value: 2.54M Avg. open price: N/A Current price: $10.03 P/L: N/A N/A Q2 2021	share	0.93%	2.54M	N/A	$10.03	N/A	N/A Q2 2021
Biotechnology CTI BioPharma Corp. Portfolio share: 0.91% Portfolio value: 2.48M Avg. open price: $2.91 Current price: $5.61 P/L: +92.78% N/A Q3 2022	share	0.91%	2.48M	$2.91	$5.61	+92.78%	N/A Q3 2022
Biotechnology Avidity Biosciences, Inc. Portfolio share: 0.90% Portfolio value: 2.45M Avg. open price: $24.04 Current price: $11.18 P/L: -53.50% Sold -38.27% shares Q2 2022	share	0.90%	2.45M	$24.04	$11.18	-53.50%	Sold -38.27% shares Q2 2022
Diagnostics & Research Twist Bioscience Corporation Portfolio share: 0.88% Portfolio value: 2.39M Avg. open price: N/A Current price: $27.74 P/L: N/A N/A Q3 2022	share	0.88%	2.39M	N/A	$27.74	N/A	N/A Q3 2022
Shell Companies Sarissa Capital Acquisition Corp. Portfolio share: 0.82% Portfolio value: 2.25M Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q3 2021	share	0.82%	2.25M	N/A	$10.05	N/A	N/A Q3 2021
Biotechnology IVERIC bio, Inc. Portfolio share: 0.82% Portfolio value: 2.24M Avg. open price: $16.24 Current price: $21.89 P/L: +34.79% Sold -47.03% shares Q3 2022	share	0.82%	2.24M	$16.24	$21.89	+34.79%	Sold -47.03% shares Q3 2022
Medical Instruments & Supplies KORU Medical Systems, Inc. Portfolio share: 0.81% Portfolio value: 2.22M Avg. open price: $4.35 Current price: $3.27 P/L: -24.89% Bought +4.34% shares Q4 2021	share	0.81%	2.22M	$4.35	$3.27	-24.89%	Bought +4.34% shares Q4 2021
Biotechnology Arcellx, Inc. Portfolio share: 0.79% Portfolio value: 2.15M Avg. open price: N/A Current price: $19.45 P/L: N/A N/A Q3 2022	share	0.79%	2.15M	N/A	$19.45	N/A	N/A Q3 2022
Biotechnology Ocular Therapeutix, Inc. Portfolio share: 0.79% Portfolio value: 2.14M Avg. open price: $13.25 Current price: $2.99 P/L: -77.43% Sold -25.59% shares Q3 2022	share	0.79%	2.14M	$13.25	$2.99	-77.43%	Sold -25.59% shares Q3 2022
Biotechnology Adicet Bio, Inc. Portfolio share: 0.78% Portfolio value: 2.13M Avg. open price: $7.84 Current price: $20.2 P/L: +157.65% Sold -3.23% shares Q2 2022	share	0.78%	2.13M	$7.84	$20.2	+157.65%	Sold -3.23% shares Q2 2022
Medical Devices Inspire Medical Systems, Inc. Portfolio share: 0.78% Portfolio value: 2.12M Avg. open price: $231.28 Current price: $234.96 P/L: +1.59% Sold -50.00% shares Q3 2022	share	0.78%	2.12M	$231.28	$234.96	+1.59%	Sold -50.00% shares Q3 2022
Biotechnology 2seventy bio, Inc. Portfolio share: 0.75% Portfolio value: 2.03M Avg. open price: $13.2 Current price: $15.36 P/L: +16.36% Bought +68.67% shares Q3 2022	share	0.75%	2.03M	$13.2	$15.36	+16.36%	Bought +68.67% shares Q3 2022
TG VENTURE ACQUISITION CORP Portfolio share: 0.74% Portfolio value: 2.02M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.74%	2.02M	N/A	N/A	N/A	N/A Q4 2021
Drug Manufacturers—Specialty & Generic Neurocrine Biosciences, Inc. Portfolio share: 0.74% Portfolio value: 2.01M Avg. open price: N/A Current price: $124 P/L: N/A Sold -13.64% shares Q3 2022	share	0.74%	2.01M	N/A	$124	N/A	Sold -13.64% shares Q3 2022
Shell Companies Lakeshore Acquisition II Corp. Portfolio share: 0.74% Portfolio value: 2.01M Avg. open price: N/A Current price: $10.13 P/L: N/A N/A Q3 2022	share	0.74%	2.01M	N/A	$10.13	N/A	N/A Q3 2022
Shell Companies Jiya Acquisition Corp. Portfolio share: 0.73% Portfolio value: 1.99M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.73%	1.99M	N/A	$10.04	N/A	N/A Q4 2020
Biotechnology uniQure N.V. Portfolio share: 0.72% Portfolio value: 1.97M Avg. open price: N/A Current price: $25.65 P/L: N/A N/A Q3 2022	share	0.72%	1.97M	N/A	$25.65	N/A	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Collegium Pharmaceutical, Inc. Portfolio share: 0.68% Portfolio value: 1.85M Avg. open price: N/A Current price: $22.73 P/L: N/A N/A Q2 2022	share	0.68%	1.85M	N/A	$22.73	N/A	N/A Q2 2022
Biotechnology Vericel Corporation Portfolio share: 0.68% Portfolio value: 1.85M Avg. open price: N/A Current price: $22.7 P/L: N/A N/A Q3 2022	share	0.68%	1.85M	N/A	$22.7	N/A	N/A Q3 2022
Biotechnology Affimed N.V. Portfolio share: 0.68% Portfolio value: 1.85M Avg. open price: N/A Current price: $2.12 P/L: N/A N/A Q3 2022	share	0.68%	1.85M	N/A	$2.12	N/A	N/A Q3 2022
Biotechnology Cara Therapeutics, Inc. Portfolio share: 0.66% Portfolio value: 1.80M Avg. open price: $12.15 Current price: $12.49 P/L: +2.80% Sold -45.36% shares Q3 2022	share	0.66%	1.80M	$12.15	$12.49	+2.80%	Sold -45.36% shares Q3 2022
Biotechnology EyePoint Pharmaceuticals, Inc. Portfolio share: 0.65% Portfolio value: 1.77M Avg. open price: $10.16 Current price: $3.33 P/L: -67.22% Sold -0.20% shares Q1 2022	share	0.65%	1.77M	$10.16	$3.33	-67.22%	Sold -0.20% shares Q1 2022
Biotechnology MediWound Ltd. Portfolio share: 0.65% Portfolio value: 1.77M Avg. open price: N/A Current price: $1.44 P/L: N/A N/A Q3 2022	share	0.65%	1.77M	N/A	$1.44	N/A	N/A Q3 2022
Biotechnology Unity Biotechnology, Inc. Portfolio share: 0.62% Portfolio value: 1.68M Avg. open price: N/A Current price: $2.93 P/L: N/A N/A Q3 2022	share	0.62%	1.68M	N/A	$2.93	N/A	N/A Q3 2022
Tools & Accessories Hillman Solutions Corp. Portfolio share: 0.61% Portfolio value: 1.66M Avg. open price: $11.06 Current price: $8.38 P/L: -24.23% Bought +12.76% shares Q2 2022	share	0.61%	1.66M	$11.06	$8.38	-24.23%	Bought +12.76% shares Q2 2022
Biotechnology Trevi Therapeutics, Inc. Portfolio share: 0.60% Portfolio value: 1.64M Avg. open price: N/A Current price: $2.09 P/L: N/A Sold -16.97% shares Q3 2022	share	0.60%	1.64M	N/A	$2.09	N/A	Sold -16.97% shares Q3 2022
Biotechnology Gossamer Bio, Inc. Portfolio share: 0.59% Portfolio value: 1.61M Avg. open price: N/A Current price: $9.29 P/L: N/A Sold -48.08% shares Q3 2022	share	0.59%	1.61M	N/A	$9.29	N/A	Sold -48.08% shares Q3 2022
Diagnostics & Research Castle Biosciences, Inc. Portfolio share: 0.57% Portfolio value: 1.56M Avg. open price: $68.84 Current price: $24.41 P/L: -64.54% N/A Q3 2022	share	0.57%	1.56M	$68.84	$24.41	-64.54%	N/A Q3 2022
Drug Manufacturers—Specialty & Generic Alkermes plc Portfolio share: 0.57% Portfolio value: 1.56M Avg. open price: $29.79 Current price: $25.51 P/L: -14.37% Bought +288.89% shares Q3 2022	share	0.57%	1.56M	$29.79	$25.51	-14.37%	Bought +288.89% shares Q3 2022
DIGITAL HEALTH ACQUISITION C Portfolio share: 0.57% Portfolio value: 1.54M Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.57%	1.54M	N/A	N/A	N/A	N/A Q4 2021
Shell Companies Ault Disruptive Technologies Corporation Portfolio share: 0.55% Portfolio value: 1.51M Avg. open price: N/A Current price: $10.12 P/L: N/A N/A Q1 2022	share	0.55%	1.51M	N/A	$10.12	N/A	N/A Q1 2022
FAT Brands Inc. Portfolio share: 0.43% Portfolio value: 1.17M Avg. open price: N/A Current price: $3.35 P/L: N/A Sold -2.87% shares Q3 2021	share	0.43%	1.17M	N/A	$3.35	N/A	Sold -2.87% shares Q3 2021
Medical Devices Quanterix Corporation Portfolio share: 0.38% Portfolio value: 1.04M Avg. open price: N/A Current price: $13 P/L: N/A N/A Q3 2022	share	0.38%	1.04M	N/A	$13	N/A	N/A Q3 2022
Biotechnology Larimar Therapeutics, Inc. Portfolio share: 0.38% Portfolio value: 1.02M Avg. open price: N/A Current price: $3.15 P/L: N/A N/A Q3 2022	share	0.38%	1.02M	N/A	$3.15	N/A	N/A Q3 2022
Shell Companies Industrial Human Capital, Inc. Portfolio share: 0.37% Portfolio value: 1.01M Avg. open price: N/A Current price: $10.22 P/L: N/A N/A Q4 2021	share	0.37%	1.01M	N/A	$10.22	N/A	N/A Q4 2021
Shell Companies Western Acquisition Ventures Corp. Portfolio share: 0.37% Portfolio value: 1.01M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q1 2022	share	0.37%	1.01M	N/A	$10.04	N/A	N/A Q1 2022
Shell Companies Relativity Acquisition Corp. Portfolio share: 0.37% Portfolio value: 1.00M Avg. open price: N/A Current price: $10.25 P/L: N/A N/A Q1 2022	share	0.37%	1.00M	N/A	$10.25	N/A	N/A Q1 2022
Shell Companies Murphy Canyon Acquisition Corp. Portfolio share: 0.37% Portfolio value: 1.00M Avg. open price: N/A Current price: $10.14 P/L: N/A N/A Q1 2022	share	0.37%	1.00M	N/A	$10.14	N/A	N/A Q1 2022
Shell Companies BCLS Acquisition Corp. Portfolio share: 0.37% Portfolio value: 1.00M Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q4 2020	share	0.37%	1.00M	N/A	$10.04	N/A	N/A Q4 2020
Shell Companies Omega Alpha SPAC Portfolio share: 0.36% Portfolio value: 993K Avg. open price: N/A Current price: $10.06 P/L: N/A N/A Q1 2021	share	0.36%	993K	N/A	$10.06	N/A	N/A Q1 2021
Shell Companies OPY Acquisition Corp. I Portfolio share: 0.36% Portfolio value: 993K Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q1 2022	share	0.36%	993K	N/A	$10.05	N/A	N/A Q1 2022
Shell Companies ARYA Sciences Acquisition Corp IV Portfolio share: 0.36% Portfolio value: 991K Avg. open price: N/A Current price: $10.05 P/L: N/A N/A Q4 2021	share	0.36%	991K	N/A	$10.05	N/A	N/A Q4 2021
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.36% Portfolio value: 985K Avg. open price: N/A Current price: $38.55 P/L: N/A N/A Q3 2022	share	0.36%	985K	N/A	$38.55	N/A	N/A Q3 2022
Biotechnology Renovacor, Inc. Portfolio share: 0.36% Portfolio value: 980K Avg. open price: N/A Current price: $3.2 P/L: N/A N/A Q3 2021	share	0.36%	980K	N/A	$3.2	N/A	N/A Q3 2021
Biotechnology Aerovate Therapeutics, Inc. Portfolio share: 0.31% Portfolio value: 846K Avg. open price: N/A Current price: $18 P/L: N/A N/A Q3 2022	share	0.31%	846K	N/A	$18	N/A	N/A Q3 2022
Shell Companies Coliseum Acquisition Corp. Portfolio share: 0.31% Portfolio value: 835K Avg. open price: N/A Current price: $9.99 P/L: N/A N/A Q3 2021	share	0.31%	835K	N/A	$9.99	N/A	N/A Q3 2021
Biotechnology Clene Inc. Portfolio share: 0.29% Portfolio value: 788K Avg. open price: N/A Current price: $1.09 P/L: N/A N/A Q3 2022	put	0.29%	788K	N/A	$1.09	N/A	N/A Q3 2022
POLISHED COM INC Portfolio share: 0.28% Portfolio value: 763K Avg. open price: N/A Current price: N/A P/L: N/A Sold -11.37% shares Q4 2021	share	0.28%	763K	N/A	N/A	N/A	Sold -11.37% shares Q4 2021
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 0.25% Portfolio value: 674K Avg. open price: N/A Current price: $4.45 P/L: N/A N/A Q3 2022	put	0.25%	674K	N/A	$4.45	N/A	N/A Q3 2022
Restaurants Muscle Maker, Inc. Portfolio share: 0.24% Portfolio value: 666K Avg. open price: N/A Current price: $0.7 P/L: N/A Sold -1.43% shares Q3 2022	share	0.24%	666K	N/A	$0.7	N/A	Sold -1.43% shares Q3 2022
Electronic Gaming & Multimedia DoubleDown Interactive Co., Ltd. Portfolio share: 0.21% Portfolio value: 562K Avg. open price: N/A Current price: $8.7 P/L: N/A Sold -61.95% shares Q4 2021	share	0.21%	562K	N/A	$8.7	N/A	Sold -61.95% shares Q4 2021
Biotechnology Palisade Bio, Inc. Portfolio share: 0.20% Portfolio value: 559K Avg. open price: N/A Current price: $4.01 P/L: N/A N/A Q3 2022	share	0.20%	559K	N/A	$4.01	N/A	N/A Q3 2022
Shell Companies GSR II Meteora Acquisition Corp. Portfolio share: 0.19% Portfolio value: 514K Avg. open price: N/A Current price: $10.04 P/L: N/A N/A Q1 2022	share	0.19%	514K	N/A	$10.04	N/A	N/A Q1 2022
Shell Companies Colombier Acquisition Corp. Portfolio share: 0.18% Portfolio value: 488K Avg. open price: N/A Current price: $9.9 P/L: N/A N/A Q3 2021	share	0.18%	488K	N/A	$9.9	N/A	N/A Q3 2021
Biotechnology PepGen Inc. Portfolio share: 0.13% Portfolio value: 363K Avg. open price: N/A Current price: $14.98 P/L: N/A Sold -50.00% shares Q3 2022	share	0.13%	363K	N/A	$14.98	N/A	Sold -50.00% shares Q3 2022
Diagnostics & Research T2 Biosystems, Inc. Portfolio share: 0.12% Portfolio value: 321K Avg. open price: N/A Current price: $1.6 P/L: N/A N/A Q3 2022	share	0.12%	321K	N/A	$1.6	N/A	N/A Q3 2022
Biotechnology Relmada Therapeutics, Inc. Portfolio share: 0.12% Portfolio value: 315K Avg. open price: N/A Current price: $4.45 P/L: N/A Sold -69.64% shares Q3 2022	share	0.12%	315K	N/A	$4.45	N/A	Sold -69.64% shares Q3 2022
WEARABLE DEVICES LTD Portfolio share: 0.11% Portfolio value: 295K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.11%	295K	N/A	N/A	N/A	N/A Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.09% Portfolio value: 253K Avg. open price: N/A Current price: $38.55 P/L: N/A N/A Q3 2022	put	0.09%	253K	N/A	$38.55	N/A	N/A Q3 2022
Biotechnology Benitec Biopharma Inc. Portfolio share: 0.09% Portfolio value: 245K Avg. open price: N/A Current price: $0.17 P/L: N/A N/A Q3 2022	share	0.09%	245K	N/A	$0.17	N/A	N/A Q3 2022
Recreational Vehicles Twin Vee Powercats Co. Portfolio share: 0.06% Portfolio value: 165K Avg. open price: N/A Current price: $2.15 P/L: N/A N/A Q3 2022	share	0.06%	165K	N/A	$2.15	N/A	N/A Q3 2022
Biotechnology Vigil Neuroscience, Inc. Portfolio share: 0.05% Portfolio value: 144K Avg. open price: N/A Current price: $12 P/L: N/A N/A Q3 2022	share	0.05%	144K	N/A	$12	N/A	N/A Q3 2022
Biotechnology NovaBay Pharmaceuticals, Inc. Portfolio share: 0.04% Portfolio value: 121K Avg. open price: N/A Current price: $1.97 P/L: N/A N/A Q3 2022	share	0.04%	121K	N/A	$1.97	N/A	N/A Q3 2022
LIGHTNING EMOTORS INC Portfolio share: 0.04% Portfolio value: 120K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.04%	120K	N/A	N/A	N/A	N/A Q1 2022
TC BIOPHARM HOLDINGS PLC Portfolio share: 0.04% Portfolio value: 118K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.04%	118K	N/A	N/A	N/A	N/A Q1 2022
Real Estate—Development Harbor Custom Development, Inc. Portfolio share: 0.04% Portfolio value: 114K Avg. open price: N/A Current price: $0.08 P/L: N/A N/A Q4 2021	share	0.04%	114K	N/A	$0.08	N/A	N/A Q4 2021
Shell Companies Health Sciences Acquisitions Corporation 2 Portfolio share: 0.04% Portfolio value: 99K Avg. open price: N/A Current price: $9.96 P/L: N/A N/A Q4 2020	share	0.04%	99K	N/A	$9.96	N/A	N/A Q4 2020
HARBOR CUSTOM DEVELOPMENT IN Portfolio share: 0.03% Portfolio value: 91K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.03%	91K	N/A	N/A	N/A	N/A Q2 2021
NEXGEL INC Portfolio share: 0.02% Portfolio value: 68K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.02%	68K	N/A	N/A	N/A	N/A Q4 2021
INNOVATIVE EYEWEAR INC Portfolio share: 0.02% Portfolio value: 60K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.02%	60K	N/A	N/A	N/A	N/A Q3 2022
CINGULATE INC Portfolio share: 0.02% Portfolio value: 59K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.02%	59K	N/A	N/A	N/A	N/A Q4 2021
RENOVACOR INC Portfolio share: 0.02% Portfolio value: 58K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.02%	58K	N/A	N/A	N/A	N/A Q3 2021
BRUUSH ORAL CARE INC Portfolio share: 0.02% Portfolio value: 52K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.02%	52K	N/A	N/A	N/A	N/A Q3 2022
Advertising Agencies Direct Digital Holdings, Inc. Portfolio share: 0.02% Portfolio value: 49K Avg. open price: N/A Current price: $0.69 P/L: N/A N/A Q1 2022	share	0.02%	49K	N/A	$0.69	N/A	N/A Q1 2022
NLS PHARMACEUTICS LTD Portfolio share: 0.02% Portfolio value: 43K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.02%	43K	N/A	N/A	N/A	N/A Q4 2021
JEFFS BRANDS LTD Portfolio share: 0.01% Portfolio value: 40K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.01%	40K	N/A	N/A	N/A	N/A Q3 2022
CEA INDUSTRIES INC Portfolio share: 0.01% Portfolio value: 38K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.01%	38K	N/A	N/A	N/A	N/A Q1 2022
LAKESHORE ACQUISITION I CORP Portfolio share: 0.01% Portfolio value: 30K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.01%	30K	N/A	N/A	N/A	N/A Q3 2021
Onfolio Holdings, Inc. Portfolio share: 0.01% Portfolio value: 30K Avg. open price: N/A Current price: $0.26 P/L: N/A N/A Q3 2022	share	0.01%	30K	N/A	$0.26	N/A	N/A Q3 2022
PEPPERLIME HEALTH ACQUSTN CO Portfolio share: 0.01% Portfolio value: 27K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.01%	27K	N/A	N/A	N/A	N/A Q4 2021
Nocturne Acquisition Corporation Portfolio share: 0.01% Portfolio value: 22K Avg. open price: N/A Current price: $0.06 P/L: N/A N/A Q2 2021	share	0.01%	22K	N/A	$0.06	N/A	N/A Q2 2021
NEXALIN TECHNOLOGY INC Portfolio share: 0.01% Portfolio value: 19K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2022	share	0.01%	19K	N/A	N/A	N/A	N/A Q3 2022
Biotechnology Surrozen, Inc. Portfolio share: 0.01% Portfolio value: 15K Avg. open price: N/A Current price: $0.05 P/L: N/A N/A Q3 2021	share	0.01%	15K	N/A	$0.05	N/A	N/A Q3 2021
Shell Companies Chavant Capital Acquisition Corp. Portfolio share: 0.00% Portfolio value: 7K Avg. open price: N/A Current price: $0.1 P/L: N/A N/A Q3 2021	share	0.00%	7K	N/A	$0.1	N/A	N/A Q3 2021
EUCRATES BIOMEDICAL ACQU COR Portfolio share: 0.00% Portfolio value: 5K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.00%	5K	N/A	N/A	N/A	N/A Q2 2021
AULT DISRUPTIVE TECHS CORP Portfolio share: 0.00% Portfolio value: 5K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.00%	5K	N/A	N/A	N/A	N/A Q1 2022
OPY ACQUISITION CORP I Portfolio share: 0.00% Portfolio value: 5K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q1 2022	share	0.00%	5K	N/A	N/A	N/A	N/A Q1 2022
GIGINTERNATIONAL1 INC Portfolio share: 0.00% Portfolio value: 3K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	3K	N/A	N/A	N/A	N/A Q3 2021
TURMERIC ACQUISITION CORP Portfolio share: 0.00% Portfolio value: 2K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q2 2021	share	0.00%	2K	N/A	N/A	N/A	N/A Q2 2021
COLOMBIER ACQUISITION CORP Portfolio share: 0.00% Portfolio value: 2K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	2K	N/A	N/A	N/A	N/A Q3 2021
Shell Companies Coliseum Acquisition Corp. Portfolio share: 0.00% Portfolio value: 2K Avg. open price: N/A Current price: $0.07 P/L: N/A N/A Q4 2021	share	0.00%	2K	N/A	$0.07	N/A	N/A Q4 2021
SARISSA CAPITAL ACQUISITN CO Portfolio share: 0.00% Portfolio value: 2K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q3 2021	share	0.00%	2K	N/A	N/A	N/A	N/A Q3 2021
INDUSTRIAL HUMAN CAPITAL INC Portfolio share: 0.00% Portfolio value: 2K Avg. open price: N/A Current price: N/A P/L: N/A N/A Q4 2021	share	0.00%	2K	N/A	N/A	N/A	N/A Q4 2021
Biotechnology Harmony Biosciences Holdings, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $60.91 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$60.91	N/A	Sold -100.00% shares Q3 2022
Shell Companies Lakeshore Acquisition I Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.06 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.06	N/A	Sold -100.00% shares Q3 2022
Medical Devices LivaNova PLC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $55.1 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$55.1	N/A	Sold -100.00% shares Q3 2022
Biotechnology Athira Pharma, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.94 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$2.94	N/A	Sold -100.00% shares Q3 2022
Auto Parts Holley Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.91 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.91	N/A	Sold -100.00% shares Q3 2022
Biotechnology ImmunoGen, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.43 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.43	N/A	Sold -100.00% shares Q3 2022
Biotechnology Amylyx Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $38.55 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$38.55	N/A	Sold -100.00% shares Q3 2022
Biotechnology Altimmune, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $11.09 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$11.09	N/A	Sold -100.00% shares Q3 2022
Biotechnology Morphic Holding, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $57.39 Current price: $26.56 P/L: -53.72% Sold -100.00% shares Q3 2022	share	0.00%	0	$57.39	$26.56	-53.72%	Sold -100.00% shares Q3 2022
Biotechnology Agios Pharmaceuticals, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $29.11 Current price: $29.8 P/L: +2.37% Sold -100.00% shares Q3 2022	share	0.00%	0	$29.11	$29.8	+2.37%	Sold -100.00% shares Q3 2022
immatics biotechnologies GmbH Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $3.48 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$3.48	N/A	Sold -100.00% shares Q3 2022
Biotechnology Rezolute, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.71 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.71	N/A	Sold -100.00% shares Q3 2022
Biotechnology LianBio Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $1.49 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$1.49	N/A	Sold -100.00% shares Q3 2022
Biotechnology Geron Corporation Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.29 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.29	N/A	Sold -100.00% shares Q3 2022
Biotechnology Sage Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $43.52 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$43.52	N/A	Sold -100.00% shares Q3 2022
Medical Devices ShockWave Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $243.11 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$243.11	N/A	Sold -100.00% shares Q3 2022
GIGINTERNATIONAL1 INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Medical Devices Sonendo, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $2.63 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$2.63	N/A	Sold -100.00% shares Q3 2022
Medical Instruments & Supplies STAAR Surgical Company Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $62.33 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$62.33	N/A	Sold -100.00% shares Q3 2022
Biotechnology Stoke Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $7.16 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$7.16	N/A	Sold -100.00% shares Q3 2022
SURGEPAYS INC Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: N/A P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	N/A	N/A	Sold -100.00% shares Q3 2022
Shell Companies Tailwind Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.16 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.16	N/A	Sold -100.00% shares Q3 2022
Biotechnology Global Blood Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $34.64 Current price: $68.49 P/L: +97.72% Sold -100.00% shares Q3 2022	share	0.00%	0	$34.64	$68.49	+97.72%	Sold -100.00% shares Q3 2022
Apparel Retail Digital Brands Group, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $5.15 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$5.15	N/A	Sold -100.00% shares Q3 2022
Biotechnology Protagonist Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $26.68 Current price: $7.8 P/L: -70.77% Sold -100.00% shares Q3 2022	call	0.00%	0	$26.68	$7.8	-70.77%	Sold -100.00% shares Q3 2022
Medical Devices DexCom, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $116.56 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$116.56	N/A	Sold -100.00% shares Q3 2022
Biotechnology Prometheus Biosciences, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $37.72 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$37.72	N/A	Sold -100.00% shares Q3 2022
Diagnostics & Research Guardant Health, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $51.95 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$51.95	N/A	Sold -100.00% shares Q3 2022
Biotechnology Kura Oncology, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $15.82 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$15.82	N/A	Sold -100.00% shares Q3 2022
Medical Devices Outset Medical, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: $45.4 Current price: $21.42 P/L: -52.82% Sold -100.00% shares Q3 2022	share	0.00%	0	$45.4	$21.42	-52.82%	Sold -100.00% shares Q3 2022
Biotechnology BridgeBio Pharma, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.17 P/L: N/A Sold -100.00% shares Q3 2022	call	0.00%	0	N/A	$9.17	N/A	Sold -100.00% shares Q3 2022
Shell Companies Chavant Capital Acquisition Corp. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $10.15 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$10.15	N/A	Sold -100.00% shares Q3 2022
Medical Devices 908 Devices Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $9.4 P/L: N/A Sold -100.00% shares Q3 2022	share	0.00%	0	N/A	$9.4	N/A	Sold -100.00% shares Q3 2022
Biotechnology Axsome Therapeutics, Inc. Portfolio share: 0.00% Portfolio value: 0 Avg. open price: N/A Current price: $77.29 P/L: N/A Sold -100.00% shares Q3 2022	put	0.00%	0	N/A	$77.29	N/A	Sold -100.00% shares Q3 2022

Showing TOP 168 ALTIUM CAPITAL MANAGEMENT LP's 13F holdings.

Frequently Asked Questions (FAQ)

What is the biggest position of ALTIUM CAPITAL MANAGEMENT LP?

The biggest position of the ALTIUM CAPITAL MANAGEMENT LP is BELLUS Health Inc. (BLU) with 4.38% portfolio share worth of 11.95M US dollars.

Top 5 ALTIUM CAPITAL MANAGEMENT LP's holdings represent 16.46% of the portfolio:

BELLUS Health Inc. (BLU) – 4.38%
Chinook Therapeutics, Inc. (KDNY) – 3.78%
ChemoCentryx, Inc. (CCXI) – 3.03%
PepperLime Health Acquisition Corporation (PEPL) – 2.69%
ADMA Biologics, Inc. (ADMA) – 2.57%

Who is the portfolio manager of ALTIUM CAPITAL MANAGEMENT LP?

The portfolio manager of the ALTIUM CAPITAL MANAGEMENT LP is .

What is the total asset value of the ALTIUM CAPITAL MANAGEMENT LP portfolio?

ALTIUM CAPITAL MANAGEMENT LP total asset value (portfolio value) is 272.76M US dollars.

Who is ?

is the portfolio manager of the ALTIUM CAPITAL MANAGEMENT LP.

What is (ALTIUM CAPITAL MANAGEMENT LP) fund performance?

ALTIUM CAPITAL MANAGEMENT LP's quarterly performance is +9.49%, annualy -31.57%.

What is the ALTIUM CAPITAL MANAGEMENT LP CIK?

ALTIUM CAPITAL MANAGEMENT LP's Central Index Key is 0001746382 .